Literature DB >> 27417001

Can 2 Pills a Day Keep Readmission Away?: Sacubitril/Valsartan to Reduce 30-Day Heart Failure Readmissions.

Robert J Mentz1, Emily C O'Brien2.   

Abstract

Entities:  

Keywords:  heart failure; outcomes; readmission; valsartan/sacubitril

Mesh：

Substances：

Year:  2016        PMID： 27417001      PMCID： PMC6278927          DOI： 10.1016/j.jacc.2016.05.013

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  13 in total

1.  What are the costs of heart failure?

Authors:  Frieder Braunschweig; Martin R Cowie; Angelo Auricchio
Journal:  Europace       Date:  2011-05       Impact factor: 5.214

2.  The multiphase optimization strategy (MOST) and the sequential multiple assignment randomized trial (SMART): new methods for more potent eHealth interventions.

Authors:  Linda M Collins; Susan A Murphy; Victor Strecher
Journal:  Am J Prev Med       Date:  2007-05       Impact factor: 5.043

3.  Has Public Reporting of Hospital Readmission Rates Affected Patient Outcomes?: Analysis of Medicare Claims Data.

Authors:  Adam D DeVore; Bradley G Hammill; N Chantelle Hardy; Zubin J Eapen; Eric D Peterson; Adrian F Hernandez
Journal:  J Am Coll Cardiol       Date:  2016-03-01       Impact factor: 24.094

4.  Illustrating bias due to conditioning on a collider.

Authors:  Stephen R Cole; Robert W Platt; Enrique F Schisterman; Haitao Chu; Daniel Westreich; David Richardson; Charles Poole
Journal:  Int J Epidemiol       Date:  2009-11-19       Impact factor: 7.196

5.  Rehospitalization for heart failure: predict or prevent?

Authors:  Akshay S Desai; Lynne W Stevenson
Journal:  Circulation       Date:  2012-07-24       Impact factor: 29.690

6.  Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure Hospitalization.

Authors:  Akshay S Desai; Brian L Claggett; Milton Packer; Michael R Zile; Jean L Rouleau; Karl Swedberg; Victor Shi; Martin Lefkowitz; Randall Starling; John Teerlink; John J V McMurray; Scott D Solomon
Journal:  J Am Coll Cardiol       Date:  2016-07-19       Impact factor: 24.094

7.  Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Authors:  Karl Swedberg; Michel Komajda; Michael Böhm; Jeffrey S Borer; Ian Ford; Ariane Dubost-Brama; Guy Lerebours; Luigi Tavazzi
Journal:  Lancet       Date:  2010-09-11       Impact factor: 79.321

8.  Angiotensin-neprilysin inhibition versus enalapril in heart failure.

Authors:  John J V McMurray; Milton Packer; Akshay S Desai; Jianjian Gong; Martin P Lefkowitz; Adel R Rizkala; Jean L Rouleau; Victor C Shi; Scott D Solomon; Karl Swedberg; Michael R Zile
Journal:  N Engl J Med       Date:  2014-08-30       Impact factor: 91.245

9.  Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

Authors:  Christopher M O'Connor; William T Abraham; Nancy M Albert; Robert Clare; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Clyde W Yancy; James B Young; Gregg C Fonarow
Journal:  Am Heart J       Date:  2008-10       Impact factor: 4.749

10.  Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.

Authors:  Milton Packer; John J V McMurray; Akshay S Desai; Jianjian Gong; Martin P Lefkowitz; Adel R Rizkala; Jean L Rouleau; Victor C Shi; Scott D Solomon; Karl Swedberg; Michael Zile; Karl Andersen; Juan Luis Arango; J Malcolm Arnold; Jan Bělohlávek; Michael Böhm; Sergey Boytsov; Lesley J Burgess; Walter Cabrera; Carlos Calvo; Chen-Huan Chen; Andrej Dukat; Yan Carlos Duarte; Andrejs Erglis; Michael Fu; Efrain Gomez; Angel Gonzàlez-Medina; Albert A Hagège; Jun Huang; Tzvetana Katova; Songsak Kiatchoosakun; Kee-Sik Kim; Ömer Kozan; Edmundo Bayram Llamas; Felipe Martinez; Bela Merkely; Iván Mendoza; Arend Mosterd; Marta Negrusz-Kawecka; Keijo Peuhkurinen; Felix J A Ramires; Jens Refsgaard; Arvo Rosenthal; Michele Senni; Antonio S Sibulo; José Silva-Cardoso; Iain B Squire; Randall C Starling; John R Teerlink; Johan Vanhaecke; Dragos Vinereanu; Raymond Ching-Chiew Wong
Journal:  Circulation       Date:  2014-11-17       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.